Biotechnology - Asia-Pacific, Licensing


Current filters:


Popular Filters

1 to 25 of 31 results

Merck Serono signs $232 million deal with Chinese company for BeiGene-290

Merck Serono signs $232 million deal with Chinese company for BeiGene-290


Merck Serono has signed a global licensing, co-development and commercialization agreement for BeiGene-290…

Asia-PacificBeiGeneBiotechnologyChinaLicensingMerck SeronoOncology

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan

Lundbeck and Otsuka partner on Biotie’s nalmefene in Japan


Biotie Therapies says that its partner, Lundbeck has expanded its existing alliance with Otsuka Pharmaceutical…

Asia-PacificBiotechnologyBiotie TherapiesLicensingLundbeckMarkets & MarketingnalmefeneNeurologicalSelincro

Immutep and Eddingpharm sign accord for ImmuFact IMP321 in China


French biopharma Immutep and Chinese drugmaker Eddingpharm have entered into an agreement for the development,…

Asia-PacificBiotechnologyLicensingMarkets & MarketingOncologyResearch

Sirona Biochem signs LoI with leading Chinese diabetes company


Canada's Sirona Biotech (TSX VENTURE:SBM) has signed a letter of intent to provide an exclusive license…

Asia-PacificBiotechnologyDiabetesFosun PharmaLicensingPharmaceuticalSGLT2Sirona BiochemWanbang Pharma

AstraZeneca to fork out $815 million for rights to anemia drug candidate


In yet another move to boost its R&D pipeline, Anglo-Swedish drug major AstraZeneca (LSE: AZN) has entered…

Asia-PacificASP1517Astellas PharmaAstraZenecaBiotechnologyFG-4592FibroGenLicensingNephrology and HepatologyNorth AmericaPharmaceuticalResearch

Soligenix collaborates with SciClone in China for SGX942 as oral mucositis therapy


US clinical-stage biopharma firm Soligenix (OTCQB: SNGX) has entered into a personalized medicine collaboration…

Asia-PacificBiotechnologyLicensingOncologyResearchSciClone PharmaSGX942Soligenix

Pharming and SIPI collaboration includes Ruconest marketing in China


Dutch biotech company Pharming Group (NYSE Euronext: PHARM) and Shanghai Institute of Pharmaceutical…

Asia-PacificBiotechnologyCardio-vascularLicensingPharmaceuticalPharmingResearchRuconestSinopharm Group

Bristol-Myers and Simcere agree to co-develop/commercialize Orencia SC in China


US pharma major Bristol-Myers Squibb (NYSE: BMY) and China-based Simcere Pharmaceutical (NYSE: SCR) have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyBristol-Myers SquibbLicensingOrenciaPharmaceuticalSimcere Pharmaceutical

Amgen and Cytokinetics expand omecamtiv mecarbil accord


USA-based Amgen (Nasdaq: AMGN), the world's largest independent biotech company, has expanded its strategic…

AmgenAsia-PacificBiotechnologyCardio-vascularCytokineticsLicensingomecamtiv mecarbil

BioLineRx collaborates with Chinese firm on hep C drug BL-8030


Israeli drug developer BioLineRx (TASE: BLRX) has signed an out-licensing agreement with Jiangsu Chia-tai…

Anti-viralsAsia-PacificBioLineRxBiotechnologyBL-8030Chia-tai Tianqing PharmaceuticalLicensingPharmaceutical

CMC Biologics and RuiYi link on MAb; Deal for Cynviloq rights in EU


Denmark and USA-based contract manufacturers CMC Biologics has entered into an agreement with China's…

Asia-PacificBiotechnologyCMC BiologicsCynviloqEuropeIGDRASOLLicensingOncologyPharmaceuticalResearchRuiYiSamyang BiopharmaceuticalsSorrento Therapeutics

Third deal for Ascletis, which gains China market rights from Janssen to a clinical stage HIV protease inhibitor


USA and China-based biotech firm Ascletis Pharmaceuticals says it has licensed development, manufacturing…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologyJanssenJohnson & JohnsonLicensingTMC310911

Roche teams up with Ascletis on hep C treatments for China


Roche (ROG: SIX) has entered a collaboration with Ascletis Pharmaceuticals, a USA- and China-based biotech…

Anti-viralsAscletis PharmaceuticalsAsia-PacificBiotechnologydanoprevirLicensingMarkets & MarketingPharmaceuticalResearchRoche

HUYA Bioscience partners with Shanghai Zhangjiang Biotech Pharmaceutical Base


HUYA Bioscience International, jointly headquartered in Shanghai, China, and in San Diego, USA, has entered…

Asia-PacificBiotechnologyHUYA BioscienceLicensingPharmaceuticalResearchShanghai Zhangjiang Biotech

CEVEC Pharma signs deal with South Korea's Yuhan


CEVEC Pharmaceuticals, a German developer of a novel human expression system derived from amniocytes,…

Asia-PacificBiotechnologyCEVEC PharmaceuticalsLicensingResearchYuhan Corp

News briefs on Ipsen/Galderma and YM BioSciences nimotuzumab assets


French drugmaker Ipsen (Euronext: IPN) and Switzerland-headquartered Galderma have expanded their collaboration…

Asia-PacificBiotechnologyCIMABDysportGaldermaInnoKeys PTEIpsenLicensingnimotuzumabOncologyPharmaceuticalSouth AmericaYM Biosciences

PharmaEssentia gets certain Asian rights to Kinex' dermatology candidate KX01


USA-based privately-held Kinex Pharmaceuticals has entered a licensing agreement granting Taiwan's PharmaEssentia…

Asia-PacificBiotechnologyDermatologicalsKinex PharmaceuticalsKX01LicensingPharmaEssentia

Alnylam gets upfront $22.5 million in RNAi link with Genzyme


French drug major Sanofi's (Euronext: SAN) US biotech subsidiary Genzyme has entered into an exclusive…

Alnylam PharmaceuticalsAsia-PacificBiotechnologyGenzymeLicensingPharmaceuticalRare diseasesSanofi

Germany seeks closer partnership with Japan in biopharmaceuticals


Germany Trade & Invest (GTI) and the Health - Made in Germany initiative will join forces at this year's…


Australian Productivity Commission reviews compulsory licensing in the patents system


The Australian Productivity Commission's review into compulsory licensing in the patents system is now…


PharmaEngine and Nanobiotix sign Asia-Pacific deal for NBTXR3


French nano-medicines group Nanobiotix has entered into a strategic partnership with PharmaEngine (TWO:…


Alnylam and Ascletis collaborate to develop ALN-VSP for liver cancers in China


US RNAi therapeutics specialties Alnylam Pharmaceuticals (Nasdaq: ALNY) and Ascletis Pharmaceuticals,…

ALN-VSPAlnylam PharmaceuticalsAscletis PharmaceuticalsAsia-PacificBiotechnologyLicensingOncology

1 to 25 of 31 results

Back to top